Archives for January, 2012

Indications that kept our investigators busy in 2011

? We tripled our phase I activity with focus on psychiatry and neurology ? 28% increase in our pain business Рmigraine, OA and chronic pain ? Psychiatry still core therapeutic area with depression and schizophrenia leading the way in 2011 ? 70% of the total business was with CROs

Read More

For 2012

Thank you to all who sent our group holiday wishes. For 2012, we aim to be responsive to our sponsors/CROs, provide quality to industry and subjects, expand our presence in Phase I and newer indications, and continue to be the go-to resource for CNS studies.

Read More